272 related articles for article (PubMed ID: 26478200)
21. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants.
Madhi SA; Dangor Z; Heath PT; Schrag S; Izu A; Sobanjo-Ter Meulen A; Dull PM
Vaccine; 2013 Aug; 31 Suppl 4():D52-7. PubMed ID: 23973347
[TBL] [Abstract][Full Text] [Related]
22. Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children.
Dzanibe S; Adrian PV; Kimaro Mlacha SZ; Madhi SA
Vaccine; 2016 Oct; 34(44):5217-5224. PubMed ID: 27663669
[TBL] [Abstract][Full Text] [Related]
23. Anti-group B Streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection.
Le Doare K; Allen L; Kampmann B; Heath PT; Taylor S; Hesseling AC; Gorringe A; Jones CE
Vaccine; 2015 Jan; 33(5):621-7. PubMed ID: 25543061
[TBL] [Abstract][Full Text] [Related]
24. Prospects for preventing infant invasive GBS disease through maternal vaccination.
Madhi SA; Dangor Z
Vaccine; 2017 Aug; 35(35 Pt A):4457-4460. PubMed ID: 28237500
[TBL] [Abstract][Full Text] [Related]
25. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program.
Harrison LH; Elliott JA; Dwyer DM; Libonati JP; Ferrieri P; Billmann L; Schuchat A
J Infect Dis; 1998 Apr; 177(4):998-1002. PubMed ID: 9534974
[TBL] [Abstract][Full Text] [Related]
26. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
[TBL] [Abstract][Full Text] [Related]
27. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
[TBL] [Abstract][Full Text] [Related]
28. Preventive procedures against GBS infection by means of antibody measurement.
Mikamo H; Higa M; Sato Y; Hayasaki Y; Hua YX; Yasuda-Kawazoe K; Tamaya T
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2000 Aug; 11(1):33-7. PubMed ID: 11004709
[TBL] [Abstract][Full Text] [Related]
29. Burden of invasive group B Streptococcus disease and early neurological sequelae in South African infants.
Dangor Z; Lala SG; Cutland CL; Koen A; Jose L; Nakwa F; Ramdin T; Fredericks J; Wadula J; Madhi SA
PLoS One; 2015; 10(4):e0123014. PubMed ID: 25849416
[TBL] [Abstract][Full Text] [Related]
30. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.
Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY
Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634
[TBL] [Abstract][Full Text] [Related]
31. Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates.
Bianchi-Jassir F; Paul P; To KN; Carreras-Abad C; Seale AC; Jauneikaite E; Madhi SA; Russell NJ; Hall J; Madrid L; Bassat Q; Kwatra G; Le Doare K; Lawn JE
Vaccine; 2020 Oct; 38(43):6682-6694. PubMed ID: 32888741
[TBL] [Abstract][Full Text] [Related]
32. Estimation of invasive Group B Streptococcus disease risk in young infants from case-control serological studies.
Izu A; Kwatra G; Madhi SA; Rigat F
BMC Med Res Methodol; 2022 Mar; 22(1):85. PubMed ID: 35350991
[TBL] [Abstract][Full Text] [Related]
33. Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads.
Madzivhandila M; Adrian PV; Cutland CL; Kuwanda L; Schrag SJ; Madhi SA
PLoS One; 2011 Mar; 6(3):e17861. PubMed ID: 21445302
[TBL] [Abstract][Full Text] [Related]
34. A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.
Hillier SL; Ferrieri P; Edwards MS; Ewell M; Ferris D; Fine P; Carey V; Meyn L; Hoagland D; Kasper DL; Paoletti LC; Hill H; Baker CJ
Clin Infect Dis; 2019 May; 68(12):2079-2086. PubMed ID: 30281066
[TBL] [Abstract][Full Text] [Related]
35. A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women.
Leroux-Roels G; Maes C; Willekens J; De Boever F; de Rooij R; Martell L; Bedell L; Wittke F; Slobod K; Dull P
Vaccine; 2016 Apr; 34(15):1786-91. PubMed ID: 26928074
[TBL] [Abstract][Full Text] [Related]
36. Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1).
Cutland CL; Schrag SJ; Thigpen MC; Velaphi SC; Wadula J; Adrian PV; Kuwanda L; Groome MJ; Buchmann E; Madhi SA
Emerg Infect Dis; 2015 Apr; 21(4):638-45. PubMed ID: 25812061
[TBL] [Abstract][Full Text] [Related]
37. Recombinant group B Streptococcus alpha-like protein 3 is an effective immunogen and carrier protein.
Yang HH; Mascuch SJ; Madoff LC; Paoletti LC
Clin Vaccine Immunol; 2008 Jul; 15(7):1035-41. PubMed ID: 18463225
[TBL] [Abstract][Full Text] [Related]
38. Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women.
Fabbrini M; Rigat F; Tuscano G; Chiarot E; Donders G; Devlieger R; Filippini S; Frigimelica E; Forte P; Wittke F; Halperin SA; Slobod K; Grandi G; Margarit I
J Infect; 2018 May; 76(5):449-456. PubMed ID: 29374589
[TBL] [Abstract][Full Text] [Related]
39. Molecular characteristics of Streptococcus agalactiae in a mother-baby prospective cohort study: Implication for vaccine development and insights into vertical transmission.
Li S; Wen G; Cao X; Guo D; Yao Z; Wu C; Ye X
Vaccine; 2018 Apr; 36(15):1941-1948. PubMed ID: 29519594
[TBL] [Abstract][Full Text] [Related]
40. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease.
Baker CJ; Carey VJ; Rench MA; Edwards MS; Hillier SL; Kasper DL; Platt R
J Infect Dis; 2014 Mar; 209(5):781-8. PubMed ID: 24133184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
